Development Level

Tchem 7 | 1,890
Tbio 1 | 10,625

Disease

Cancer 6 | 2,346
psoriasis 6 | 6,685
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,289
medulloblastoma, large-cell 5 | 6,234
osteosarcoma 5 | 7,933
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
ovarian cancer 4 | 8,484
Acute kidney injury 3 | 65
Adverse reaction to drug 3 | 54
Liver disease 3 | 219
Precursor Cell Lymphoblastic Leukemia Lymphoma 3 | 42
Prostatic Neoplasms 3 | 471
glioblastoma 3 | 5,572
lung carcinoma 3 | 2,844
pancreatic cancer 3 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
tuberculosis 3 | 1,557
Cardiomegaly 2 | 66
Cerebrovascular disease 2 | 231
Chronic Obstructive Airway Disease 2 | 47
Colorectal Neoplasms 2 | 217
Contact Dermatitis 2 | 80
Drug-Induced Liver Injury 2 | 118
Epilepsy 2 | 346
Lung Injury 2 | 20
Lung Neoplasms 2 | 171
Mammary Neoplasms 2 | 410
Squamous cell carcinoma 2 | 94
adrenocortical carcinoma 2 | 1,427
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
diabetes mellitus 2 | 1,663
group 3 medulloblastoma 2 | 2,254
group 4 medulloblastoma 2 | 1,875
lung cancer 2 | 4,466
nervous system disorder 2 | 53
oligodendroglioma 2 | 2,849
posterior fossa group A ependymoma 2 | 1,511
primitive neuroectodermal tumor 2 | 3,031
substance-related disorder 2 | 105
ulcerative colitis 2 | 2,087
Aniridia 1 | 26
Aspergillosis 1 | 23
Asthma management 1 | 20
Atrophic 1 | 10
Autoimmune hepatitis 1 | 13
Axenfeld-Rieger syndrome 1 | 11
Balkan Nephropathy 1 | 6
Blindness 1 | 84
Brain Neoplasms 1 | 23
COPD 1 | 113
Carcinoma of thyroid 1 | 17
Cardiomyopathies 1 | 90
Cardiovascular system disease 1 | 194
Corneal disease 1 | 32
Dental caries 1 | 67
Diabetes Mellitus, Experimental 1 | 106
Drug Eruptions 1 | 18
Drug allergy 1 | 36
Esophagitis 1 | 26
GLAUCOMA 1, OPEN ANGLE, A 1 | 3
GLAUCOMA 3, PRIMARY CONGENITAL, A 1 | 2
Gastritis 1 | 44
Gastroesophageal reflux disease 1 | 37
Gastrointestinal stromal tumor 1 | 61
Gaucher disease type 1 1 | 171
Glaucoma 1 | 134
Growth Disorders 1 | 33
Heart failure 1 | 80
Hepatomegaly 1 | 10
Hypersensitivity 1 | 63
Irido-corneo-trabecular dysgenesis (disorder) 1 | 6
Kidney Diseases 1 | 86
Kidney Failure, Chronic 1 | 45
Kidney Neoplasm 1 | 27
Liver Cirrhosis, Experimental 1 | 108
Liver Neoplasms, Experimental 1 | 48
Liver cell carcinoma 1 | 15
Liver diseases 1 | 66
Major Depressive Disorder 1 | 106
Mastitis 1 | 48
Melanoma 1 | 261
Metastasis from malignant tumor of colon 1 | 8
Metastatic Breast Cancer Progression Post-Antiestrogen Therapy 1 | 4
Metastatic Prostate Carcinoma 1 | 18
Mouth Neoplasms 1 | 42
Neural Tube Defects 1 | 27
Osteonecrosis 1 | 25
Renal Cell Carcinoma 1 | 199
Staphyloenterotoxemia 1 | 20
Toxic shock syndrome 1 | 28
atypical teratoid/rhabdoid tumor 1 | 1,095
cystic fibrosis and chronic rhinosinusitis 1 | 213
fascioscapulohumeral muscular dystrophy 1 | 100
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
limb girdle muscular dystrophy 2B 1 | 74
ovarian neoplasm 1 | 97
sarcoidosis 1 | 358

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Non-IDG 7 | 11,971
Enzyme 1 | 4,146

Reactome Pathway

Synthesis of epoxy (EET) and d... 8 | 8
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cytochrome P450 2J2 CYP2J2 Tchem Non-IDG -2.03738 133.3 162
Cytochrome P450 1A1 CYP1A1 Tchem Non-IDG -3.52997 3553.5 340
Cytochrome P450 2C19 CYP2C19 Tchem Non-IDG -3.17457 1627.4 145
Bifunctional epoxide hydrolase 2 EPHX2 Tchem Enzyme -2.45477 305.1 200
Cytochrome P450 2C8 CYP2C8 Tbio Non-IDG -2.50903 331.1 134
Cytochrome P450 2C9 CYP2C9 Tchem Non-IDG -3.17625 1560.3 155
Cytochrome P450 1B1 CYP1B1 Tchem Non-IDG -2.90618 863.4 217
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420